Concepedia

Simon Piggott

SP

Statistics

Publications

7

Citations

463

H-Index

7

Active since

1990

Affiliations

Novartis (Switzerland)(Current)

Novartis (United States)

University of Wales

Simon Piggott is an author at Novartis (Switzerland) specializing in pharmacotherapy, medicine, and pulmonary function testing.

Publications per year

1990–2013

7

Publications

7

Efficacy and safety of indacaterol 150 μg once-daily in COPD: a double-blind, randomised, 12-week study

Gregory Feldman, Thomas M. Siler, Niyati Prasad et al. · BMC Pulmonary Medicine · 2010 · 119 citations · Full text

, , +17

Indacaterol provides 24-hour bronchodilation in COPD: a placebo-controlled blinded comparison with tiotropium

Claus Vogelmeier, David Ramos‐Barbón, Damon Jack et al. · Respiratory Research · 2010 · 89 citations · Full text

, , +16

Cognitive and functional competence after anaesthesia in patients aged over 60: controlled trial of general and regional anaesthesia for elective hip or knee replacement.

Michael Jones, Simon Piggott, R. S. Vaughan et al. · BMJ · 1990 · 87 citations · Full text

, , +15

ISOFLURANE WITH EITHER 100% OXYGEN OR 50% NITROUS OXIDE IN OXYGEN FOR CAESAREAN SECTION

Simon Piggott, D. G. Bogod, Michael J. Rosen et al. · British Journal of Anaesthesia · 1990 · 53 citations · Full text

, , +7

Tobramycin inhalation powder manufactured by improved process in cystic fibrosis: the randomized EDIT trial

Ivanka Galeva, Michael W. Konstan, Mark Higgins et al. · Current Medical Research and Opinion · 2013 · 44 citations · Full text

, , +17

1–5 of 7